Search Results - "Onida, F"

Autologous hematopoietic stem cell transplantation has better outcomes than conventional therapies in patients with rapidly progressive systemic sclerosis by Del Papa, N, Onida, F, Zaccara, E, Saporiti, G, Maglione, W, Tagliaferri, E, Andracco, R, Vincenti, D, Montemurro, T, Mircoli, L, Vitali, C, Cortelezzi, A

“…We retrospectively evaluated the efficacy of autologous hematopoietic stem cell transplantation (AHSCT) in 18 patients with rapidly progressive diffuse…”
Get full text

Treosulfan, thiotepa and fludarabine conditioning regimen prior to first allogeneic stem cell transplantation in acute myeloid leukemia and high-risk myelodysplastic syndromes: a single center experience by Cassanello, G., Serpenti, F., Bagnoli, F., Saporiti, G., Goldaniga, M., Cavallaro, F., Barbullushi, K., Bellani, V., Galassi, G., Onida, F.

Get full text

A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia by Santini, V, Allione, B, Zini, G, Gioia, D, Lunghi, M, Poloni, A, Cilloni, D, Sanna, A, Masiera, E, Ceccarelli, M, Abdel-Wahab, O, Terenzi, A, Angelucci, E, Finelli, C, Onida, F, Pelizzari, A, Ferrero, D, Saglio, G, Figueroa, M, Levis, A

“…Chronic myelomonocytic leukemia (CMML) is a complex clonal hematological disorder classified among myelodysplastic (MDS)/myeloproliferative neoplasms…”
Get full text

Clinicopathological definition, management and prognostic value of mogamulizumab-associated rash and other cutaneous events: A systematic review by Avallone, G, Roccuzzo, G, Pileri, A, Agostinelli, C, Maronese, C A, Aquino, C, Tavoletti, G, Onida, F, Fava, P, Ribero, S, Marzano, A V, Berti, E, Quaglino, P, Alberti-Violetti, S

“…Mogamulizumab is a first-in-class IgG1k monoclonal antibody that selectively targets the chemokine receptor type 4. The drug has received Food and Drug…”
Get full text

Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation by Domingo-Domenech, E., Duarte, R. F., Boumedil, A., Onida, F., Gabriel, I., Finel, H., Arcese, W., Browne, P., Beelen, D., Kobbe, G., Veelken, H., Arranz, R., Greinix, H., Lenhoff, S., Poiré, X., Ribera, J. M., Thompson, J., Zuckerman, T., Mufti, G. J., Cortelezzi, A., Olavarria, E., Dreger, P., Sureda, A., Montoto, S.

“…Background Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potentially curative treatment option in advanced-stage mycosis fungoides (MF)…”
Get full text

Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission by Saraceni, F, Bruno, B, Lemoli, R M, Meloni, G, Arcese, W, Falda, M, Ciceri, F, Alessandrino, E P, Specchia, G, Scimè, R, Raimondi, R, Bacigalupo, A, Bosi, A, Onida, F, Rambaldi, A, Bonifazi, F, Olivieri, A

Get full text

An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategies by Padron, E, Garcia-Manero, G, Patnaik, M M, Itzykson, R, Lasho, T, Nazha, A, Rampal, R K, Sanchez, M E, Jabbour, E, Al Ali, N H, Thompson, Z, Colla, S, Fenaux, P, Kantarjian, H M, Killick, S, Sekeres, M A, List, A F, Onida, F, Komrokji, R S, Tefferi, A, Solary, E

“…Since its reclassification as a distinct disease entity, clinical research efforts have attempted to establish baseline characteristics and prognostic scoring…”
Get full text

Nilotinib in steroid-refractory cGVHD: prospective parallel evaluation of response, according to NIH criteria and exploratory response criteria (GITMO criteria) by Olivieri, A., Mancini, G., Olivieri, J., Marinelli Busilacchi, E., Cimminiello, M., Pascale, S. P., Nuccorini, R., Patriarca, F., Corradini, P., Bacigalupo, A., Angelini, S., Poloni, A., Grillo, G., Onida, F., Martino, M., Di Renzo, N., Nagler, A., Mordini, N., Bruno, B., Ciceri, F., Bonifazi, F.

“…We conducted a phase I–II study to evaluate Nilotinib (NIL) safety and pharmacokinetics in 22 SR-cGVHD patients; we also evaluated ORR by using in parallel NIH…”
Get full text

Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease by Cassinotti, A, Annaloro, C, Ardizzone, S, Onida, F, Della Volpe, A, Clerici, M, Usardi, P, Greco, S, Maconi, G, Porro, G Bianchi, Deliliers, G Lambertenghi

“…Autologous haematopoietic stem cell transplantation (HSCT) with CD34(+) cell selection has recently been used in the treatment of refractory Crohn's disease,…”
Get more information

Management recommendations for chronic myelomonocytic leukemia: consensus statements from the SIE, SIES, GITMO groups by Onida, Francesco, Barosi, Giovanni, Leone, Giuseppe, Malcovati, Luca, Morra, Enrica, Santini, Valeria, Specchia, Giorgina, Tura, Sante

“…With the aim of reviewing critical concepts and producing recommendations for the management of chronic myelomonocytic leukemia, key questions were selected…”
Get full text

Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome by Patnaik, M M, Wassie, E A, Padron, E, Onida, F, Itzykson, R, Lasho, T L, Kosmider, O, Finke, C M, Hanson, C A, Ketterling, R P, Komrokji, R, Tefferi, A, Solary, E

“…In patients with chronic myelomonocytic leukemia (CMML), age>65 years is an adverse prognostic factor. Our objective in the current study was to examine risk…”
Get full text

PB1840: MONOCENTRIC EXPERIENCE OF VENETOCLAX‐BASED REGIMENS FOR ACUTE MYELOID LEUKEMIA by Sciumè, M., Bosi, A., Ceparano, G., De Magistris, C., Serpenti, F., De Roberto, P., Galassi, G., Onida, F., Fracchiolla, N. S.

Get full text

‘Real-life’ report on the management of chronic GvHD in the Gruppo Italiano Trapianto Midollo Osseo (GITMO) by Giaccone, L, Mancini, G, Mordini, N, Gargiulo, G, De Cecco, V, Angelini, S, Arpinati, M, Baronciani, D, Bozzoli, V, Bramanti, S, Calore, E, Cavattoni, I M, Cimminiello, M, Colombo, A A, Facchini, L, Falcioni, S, Faraci, M, Fedele, R, Guidi, S, Iori, A P, Marotta, S, Micò, M C, Milone, G, Onida, F, Pastore, D, Patriarca, F, Pini, M, Raimondi, R, Rovelli, A, Santarone, S, Severino, A, Skert, C, Stanghellini, M T L, Tecchio, C, Vassallo, E, Chiarucci, M, Bruno, B, Bonifazi, F, Olivieri, A

“…Several guidelines have been published about management of chronic GvHD (cGvHD), but the clinical practice still remains demanding. The Gruppo Italiano…”
Get full text

Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome by Patnaik, M M, Wassie, E A, Padron, E, Onida, F, Itzykson, R, Lasho, T L, Kosmider, O, Finke, C M, Hanson, C A, Ketterling, R P, Komrokji, R, Tefferi, A, Solary, E

Get full text

Pulmonary arterial hypertension in primary myelofibrosis is common and associated with an altered angiogenic status by Cortelezzi, A, Gritti, G, Del Papa, N, Pasquini, M C, Calori, R, Gianelli, U, Cortiana, M, Parati, G, Onida, F, Sozzi, F, Vener, C, Bianchi, P, Deliliers, G L

Get full text

Cancer stem cells in hematological disorders: current and possible new therapeutic approaches by Annaloro, C, Onida, F, Saporiti, G, Lambertenghi Deliliers, G

“…An increasing body of evidence has shown that hematologic malignancies, alike normal hematopoiesis, has a hierarchical structure including a stem cell…”
Get more information

Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative BCR-ABL-negative chronic myelogenous leukemia by MITTAL, P, SALIBA, R. M, GIRALT, S. A, SHAHJAHAN, M, COHEN, A. I, KARANDISH, S, ONIDA, F, BERAN, M, CHAMPLIN, R. E, DE LIMA, M

“…The role of allogeneic transplantation for myeloproliferative diseases other than chronic myeloid leukemia is not well established. In all, 20 patients with a…”
Get full text

166 TARGETED SEQUENCING ANALYSIS OF COMMONLY MUTATED GENES IN CHRONIC MYELOMONOCYTIC LEUKEMIA USING NGS: IMPACT AND CLINICAL IMPLICATIONS by Valencia, A, Abdel-Wahab, O, Buchi, F, Masala, E, Sanna, A, Gozzini, A, Figueroa, M.E, Contini, E, Torricelli, F, Allione, B, Lunghi, M, Onida, F, Polloni, A, Angelucci, E, Finelli, F, Levis, A, Gioia, D, Bosi, A, Santini, V

Get full text

O-018 Efficacy of decitabine in advanced chronic myelomonocytic leukemia (CMML) patients by Santini, V, Allione, B, Lunghi, M, Levis, A, Poloni, A, Angelucci, E, Onida, F, Terenzi, A, Finelli, C, Ferrero, D

Get full text

OC.03.3 AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION WITHOUT CD34+ CELL SELECTION FOR REFRACTORY CROHN'S DISEASE: THE MILAN EXPERIENCE AFTER 5 YEARS by Cassinotti, A, Onida, F, Annaloro, C, Sampietro, G, Fociani, P, Fichera, M, Maconi, G, Lombardini, M, Bezzio, C, Foschi, D, Deliliers, G. Lambertenghi, Porro, G. Bianchi, De Franchis, R, Ardizzone, S

Get full text